Squarepoint’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,806
Closed -$74.9K 4966
2025
Q2
$74.9K Sell
15,806
-41,724
-73% -$195K ﹤0.01% 4231
2025
Q1
$272K Sell
57,530
-28,147
-33% -$164K ﹤0.01% 3808
2024
Q4
$593K Buy
85,677
+54,576
+175% +$400K ﹤0.01% 3586
2024
Q3
$180K Buy
31,101
+14,081
+83% +$85.5K ﹤0.01% 3723
2024
Q2
$90.7K Buy
17,020
+4,273
+34% +$19.6K ﹤0.01% 3818
2024
Q1
$48.4K Buy
+12,747
New +$46.2K ﹤0.01% 3881
2023
Q3
Sell
-11,200
Closed -$35.3K 4218
2023
Q2
$35.3K Sell
11,200
-789
-7% -$2.85K ﹤0.01% 3464
2023
Q1
$62.5K Buy
+11,989
New +$86.1K ﹤0.01% 3029

Other funds holding SRTS

Squarepoint's SRTS Position: Q3 2025 in Review

Squarepoint sold out of Sensus Healthcare (SRTS) in Q3 2025, closing a stake of 15,806 shares — an estimated $74.9K sold.

Squarepoint first reported a position in SRTS in Q1 2023 and held it in 8 quarters. The position peaked at $593K in Q4 2024. 42 funds tracked by Wall St. Rank hold SRTS as of Q3 2025.

  • Squarepoint reported no remaining Sensus Healthcare position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 15,806 Sensus Healthcare shares in Q3 2025, an estimated $74.9K.
  • Squarepoint first reported a position in Sensus Healthcare in Q1 2023 and held it in 8 quarters.
  • Squarepoint's Sensus Healthcare position peaked at $593K in Q4 2024.
  • 42 funds tracked by Wall St. Rank held Sensus Healthcare as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.